Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx® GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers More
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
Jeffrey A. Niezgoda, M.D., F.A.C.E.P., and Eliot N. Mostow, M.D., M.P.H. announced interim analysis on the performance of HEALTHPOINT's innovative wound care product, OASIS Wound Matrix More
Jeffrey A. Niezgoda, M.D., F.A.C.E.P., and Eliot N. Mostow, M.D., M.P.H. announced interim analysis on the performance of HEALTHPOINT's innovative wound care product, OASIS Wound Matrix More